NANOSNET

 View Only
  • 1.  Spectralis OCT GCL for chiasmopathy

    Posted 08-18-2025 19:04

    Wondering if anyone is using Spectralis OCT GCL to detect early signs of chiasmopathy in pituitary tumors and what microns are being used as normal findings?



    ------------------------------
    Nancy
    ------------------------------


  • 2.  RE: Spectralis OCT GCL for chiasmopathy

    Posted 08-18-2025 20:19

    I've been using spectralis for the past 9 years, although not exclusively. Here are some of the tips:

    1. As with RNFL, it is better for progression rather than using absolute cut-offs as there is wide anatomic variance and other conditions may impact baseline GCL
    2. I use the 1,2,3 mm ring, some general guidelines:
      a. 0.30 mm3 volume and above is normal
      b. 0.26-0.3 mm3 would be borderline
      c. 0.22-0.26 mm3 would be mild thinning
      d. 0.18-0.22 mm3 would be moderate thinning
      e. <0.18 mm3 would be severe thinning - it tends to bottom out around 0.12-0.14 mm3
    3. for chiasmal disease specifically on the Spectralis, you can compare the macula GCL nasal quadrant to temporal quadrant (macula nasal-temporal ratio = mNTR): When distinguishing chiasmal compression from POAG, an optimal diagnostic mNTR threshold of <0.99 was identified (nasal thinner than temporal), which was associated a specificity of 100% and a sensitivity of 84%. When comparing with healthy controls, a mean mNTR threshold of <0.96 was associated with a specificity of 100% and a sensitivity of 77% in identifying chiasmal compression and an NTR threshold of >1.06 was associated with a specificity of 88% and a sensitivity of 60% in identifying glaucoma - (Kleerekooper et al. Differentiating glaucoma from chiasmal compression using optical coherence tomography: the macular naso-temporal ratio. Br J Ophthalmol. 2024 May).

    Best,

    Drew



    ------------------------------
    Andrew Carey
    Associate Professor
    Wilmer Eye Institute, Johns Hopkins Medicine
    Baltimore MD
    ------------------------------



  • 3.  RE: Spectralis OCT GCL for chiasmopathy

    Posted 08-19-2025 05:03

    Andrew,

    Thank you very much. This is very helpful.

    Nancy



    ------------------------------
    Nancy
    ------------------------------



  • 4.  RE: Spectralis OCT GCL for chiasmopathy

    Posted 08-19-2025 05:19

    Hello,

    Sectorial GCL thinning can often be identified in the Deviation Map of the PPoleH Scan included in the Glaucoma Module Premium Edition of Spectralis. It compares GCL thickness to a reference database similar to the Cirrus OCT (which measures GCIPL).

    Best,

    Berthold

    -------------------------------------------



  • 5.  RE: Spectralis OCT GCL for chiasmopathy

    Posted 08-19-2025 05:20
    There are variations in the Heidelberg software packages between departments/practices.  I don't have familiarity with the specialised neuro-ophthalmology package.  

    If you have an updated glaucoma package, then you can collect a macular scan in the glaucoma module (rather than the retina module).  These glaucoma macular scans are called "PPole-H" (posterior pole with horizontal slices), and they are rotated slightly to align with the fovea-disc axis, so as to better align with the horizontal raphe of RGC axons.  If you collect one of these PPoleH scans in the glaucoma module, it should have an additional tab called Deviation Map which shows which parts of the GCL are outside of their Heidelberg normal database. 

    However, in my experience there is a lot of variation with myopes, young and old patients, variations in foveal shape, and so there are both false positives and false negatives when using these deviation maps (even in the context of glaucoma).  I think that's often true with the Zeiss GCL maps too but I have less experience with their system.  When looking for thinning of GCL in an optic neuropathy I think it is much more powerful to look at regional patterns of relative thinning which correlate to RNFL or VF, for example thinning respecting the horizontal or vertical meridians, rather than deciding what is normal from the deviation map. 

    BW
    Jesse
    Wellington, NZ